• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用 PLGA 纳米粒实现抗生素向细胞内衣原体感染的靶向递送。

Targeted delivery of antibiotics to intracellular chlamydial infections using PLGA nanoparticles.

机构信息

Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA.

出版信息

Biomaterials. 2011 Sep;32(27):6606-13. doi: 10.1016/j.biomaterials.2011.05.038. Epub 2011 Jun 8.

DOI:10.1016/j.biomaterials.2011.05.038
PMID:21652065
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3133877/
Abstract

Chlamydia trachomatis and Chlamydia pneumoniae are intracellular bacterial pathogens that have been shown to cause, or are strongly associated with, diverse chronic diseases. Persistent infections by both organisms are refractory to antibiotic therapy. The lack of therapeutic efficacy results from the attenuated metabolic rate of persistently infecting chlamydiae in combination with the modest intracellular drug concentrations achievable by normal delivery of antibiotics to the inclusions within which chlamydiae reside in the host cell cytoplasm. In this research, we evaluated whether nanoparticles formulated using the biodegradable poly(d-L-lactide-co-glycolide) (PLGA) polymer can enhance the delivery of antibiotics to the chlamydial inclusion complexes. We initially studied the trafficking of PLGA nanoparticles in Chlamydia-infected cells. We then evaluated nanoparticles for the delivery of antibiotics to the inclusions. Intracellular trafficking studies show that PLGA nanoparticles efficiently concentrate in inclusions in both acutely and persistently infected cells. Further, encapsulation of rifampin and azithromycin antibiotics in PLGA nanoparticles enhanced the effectiveness of the antibiotics in reducing microbial burden. Combination of rifampin and azithromycin was more effective than the individual drugs. Overall, our studies show that PLGA nanoparticles can be effective carriers for targeted delivery of antibiotics to intracellular chlamydial infections.

摘要

沙眼衣原体和肺炎衣原体是胞内细菌病原体,已被证明可引起或与多种慢性疾病密切相关。这两种病原体的持续感染对抗生素治疗有抗性。缺乏治疗效果是由于持续感染的衣原体代谢率降低,以及抗生素通过正常途径递送至宿主细胞质中衣原体所在的包含体中的细胞内药物浓度适中。在这项研究中,我们评估了使用可生物降解的聚(D-丙交酯-共-乙交酯)(PLGA)聚合物制成的纳米颗粒是否可以增强抗生素向衣原体包含物复合物的递送。我们首先研究了 PLGA 纳米颗粒在感染衣原体的细胞中的转运。然后,我们评估了纳米颗粒将抗生素递送至包含物的能力。细胞内转运研究表明,PLGA 纳米颗粒在急性和持续性感染细胞中均能有效地在包含物中浓缩。此外,将利福平(rifampin)和阿奇霉素(azithromycin)抗生素包封在 PLGA 纳米颗粒中增强了抗生素降低微生物负担的效果。利福平与阿奇霉素联合使用比单独使用这两种药物更有效。总的来说,我们的研究表明,PLGA 纳米颗粒可以作为靶向递送至细胞内衣原体感染的有效载体。

相似文献

1
Targeted delivery of antibiotics to intracellular chlamydial infections using PLGA nanoparticles.使用 PLGA 纳米粒实现抗生素向细胞内衣原体感染的靶向递送。
Biomaterials. 2011 Sep;32(27):6606-13. doi: 10.1016/j.biomaterials.2011.05.038. Epub 2011 Jun 8.
2
PAMAM dendrimer-azithromycin conjugate nanodevices for the treatment of Chlamydia trachomatis infections.PAMAM 树枝状大分子-阿奇霉素偶联纳米器件治疗沙眼衣原体感染。
Nanomedicine. 2011 Dec;7(6):935-44. doi: 10.1016/j.nano.2011.04.008. Epub 2011 May 19.
3
Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro.阿奇霉素和利福平对沙眼衣原体体外感染的影响。
Antimicrob Agents Chemother. 2001 Nov;45(11):3001-8. doi: 10.1128/AAC.45.11.3001-3008.2001.
4
Preparation of siRNA-encapsulated PLGA nanoparticles for sustained release of siRNA and evaluation of encapsulation efficiency.用于小干扰RNA(siRNA)持续释放的包裹siRNA的聚乳酸-羟基乙酸共聚物(PLGA)纳米颗粒的制备及包封率评估。
Methods Mol Biol. 2012;906:311-9. doi: 10.1007/978-1-61779-953-2_25.
5
Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited.聚乳酸-乙醇酸共聚物纳米颗粒介导的细胞内药物递送研究新进展
Mol Pharm. 2009 Jan-Feb;6(1):190-201. doi: 10.1021/mp800137z.
6
Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine.沙眼衣原体重组 MOMP 包被于 PLGA 纳米粒中可在小鼠体内主要引发 T 辅助细胞 1 型细胞及体液免疫应答:一种理想的候选纳米疫苗。
Int J Nanomedicine. 2013;8:2085-99. doi: 10.2147/IJN.S44155. Epub 2013 May 30.
7
Potential antibacterial activity of carvacrol-loaded poly(DL-lactide-co-glycolide) (PLGA) nanoparticles against microbial biofilm.载香芹酚的聚(DL-丙交酯-共-乙交酯)(PLGA)纳米颗粒对微生物生物膜的潜在抗菌活性
Int J Mol Sci. 2011;12(8):5039-51. doi: 10.3390/ijms12085039. Epub 2011 Aug 8.
8
The potential for the noninvasive delivery of polymeric nanocarriers using propellant-based inhalers in the treatment of Chlamydial respiratory infections.利用推进剂式吸入器对聚合物纳米载体进行非侵入式给药,治疗衣原体呼吸道感染的潜力。
Biomaterials. 2010 Oct;31(28):7376-85. doi: 10.1016/j.biomaterials.2010.06.005.
9
Polymeric nanoparticles for siRNA delivery and gene silencing.用于siRNA递送和基因沉默的聚合物纳米颗粒。
Int J Pharm. 2009 Feb 9;367(1-2):195-203. doi: 10.1016/j.ijpharm.2008.09.039. Epub 2008 Oct 1.
10
Transferrin-conjugated lipid-coated PLGA nanoparticles for targeted delivery of aromatase inhibitor 7alpha-APTADD to breast cancer cells.转铁蛋白偶联脂质体包被的 PLGA 纳米粒用于芳香酶抑制剂 7alpha-APTADD 向乳腺癌细胞的靶向递送。
Int J Pharm. 2010 May 10;390(2):234-41. doi: 10.1016/j.ijpharm.2010.02.008. Epub 2010 Feb 13.

引用本文的文献

1
Combating Antimicrobial Resistance: Innovative Strategies Using Peptides, Nanotechnology, Phages, Interference, and CRISPR-Cas Systems.对抗抗菌药物耐药性:使用肽、纳米技术、噬菌体、干扰和CRISPR-Cas系统的创新策略
Pharmaceuticals (Basel). 2025 Jul 27;18(8):1119. doi: 10.3390/ph18081119.
2
The Next Frontier: Unveiling Novel Approaches for Combating Multidrug-Resistant Bacteria.下一个前沿领域:揭示对抗多重耐药细菌的新方法。
Pharm Res. 2025 Jun 16. doi: 10.1007/s11095-025-03871-x.
3
Revolutionizing Nanovaccines: A New Era of Immunization.变革性纳米疫苗:免疫接种的新时代。
Vaccines (Basel). 2025 Jan 27;13(2):126. doi: 10.3390/vaccines13020126.
4
Salmon-IgM Functionalized-PLGA Nanosystem for Florfenicol Delivery as an Antimicrobial Strategy against .用于氟苯尼考递送的鲑鱼免疫球蛋白M功能化聚乳酸-羟基乙酸共聚物纳米系统作为一种抗……的抗菌策略
Nanomaterials (Basel). 2024 Oct 16;14(20):1658. doi: 10.3390/nano14201658.
5
Bacterial infection microenvironment-responsive porous microspheres by microfluidics for promoting anti-infective therapy.用于促进抗感染治疗的微流控细菌感染微环境响应性多孔微球
Smart Med. 2022 Dec 16;1(1):e20220012. doi: 10.1002/SMMD.20220012. eCollection 2022 Dec.
6
3D-printed dual drug delivery nanoparticle- loaded hydrogels to combat antibiotic-resistant bacteria.用于对抗抗生素耐药细菌的3D打印载有双药递送纳米颗粒的水凝胶。
Int J Bioprint. 2023 Feb 13;9(3):683. doi: 10.18063/ijb.683. eCollection 2023.
7
PLGA Particles in Immunotherapy.免疫疗法中的聚乳酸-羟基乙酸共聚物微粒
Pharmaceutics. 2023 Feb 11;15(2):615. doi: 10.3390/pharmaceutics15020615.
8
Nanomedicine: New Frontiers in Fighting Microbial Infections.纳米医学:对抗微生物感染的新前沿。
Nanomaterials (Basel). 2023 Jan 25;13(3):483. doi: 10.3390/nano13030483.
9
Recent Developments in Drug Delivery for Treatment of Tuberculosis by Targeting Macrophages.靶向巨噬细胞治疗结核病的药物递送最新进展
Adv Ther (Weinh). 2022 Jun;5(6). doi: 10.1002/adtp.202100193. Epub 2022 Mar 9.
10
PLGA-Based Composites for Various Biomedical Applications.用于各种生物医学应用的基于聚乳酸-羟基乙酸共聚物的复合材料
Int J Mol Sci. 2022 Feb 12;23(4):2034. doi: 10.3390/ijms23042034.

本文引用的文献

1
Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial.联合使用抗生素治疗慢性衣原体诱导的反应性关节炎:一项双盲、安慰剂对照的前瞻性试验。
Arthritis Rheum. 2010 May;62(5):1298-307. doi: 10.1002/art.27394.
2
New insights into Chlamydia intracellular survival mechanisms.对衣原体细胞内生存机制的新认识。
Cell Microbiol. 2009 Nov;11(11):1571-8. doi: 10.1111/j.1462-5822.2009.01364.x. Epub 2009 Aug 5.
3
Chlamydia trachomatis Can Persist in Joint Tissue After Antibiotic Treatment in Chronic Reiter's Syndrome / Reactive Arthritis.沙眼衣原体在慢性反应性关节炎/赖特综合征的抗生素治疗后可在关节组织中持续存在。
J Clin Rheumatol. 1997 Jun;3(3):125-30. doi: 10.1097/00124743-199706000-00001.
4
Single-step surface functionalization of polymeric nanoparticles for targeted drug delivery.用于靶向药物递送的聚合物纳米颗粒的单步表面功能化
Biomaterials. 2009 Feb;30(5):859-66. doi: 10.1016/j.biomaterials.2008.09.056. Epub 2008 Nov 18.
5
Cytoplasmic lipid droplets are translocated into the lumen of the Chlamydia trachomatis parasitophorous vacuole.细胞质脂滴被转运至沙眼衣原体包涵体的腔内。
Proc Natl Acad Sci U S A. 2008 Jul 8;105(27):9379-84. doi: 10.1073/pnas.0712241105. Epub 2008 Jun 30.
6
UEA I-bearing nanoparticles for brain delivery following intranasal administration.经鼻给药后用于脑递送的载有荆豆凝集素I的纳米颗粒。
Int J Pharm. 2007 Aug 1;340(1-2):207-15. doi: 10.1016/j.ijpharm.2007.03.039. Epub 2007 Mar 30.
7
Preparation of hemoglobin-loaded nano-sized particles with porous structure as oxygen carriers.制备具有多孔结构的负载血红蛋白的纳米级颗粒作为氧载体。
Biomaterials. 2007 Mar;28(7):1414-22. doi: 10.1016/j.biomaterials.2006.10.012. Epub 2006 Nov 28.
8
Trafficking from CD63-positive late endocytic multivesicular bodies is essential for intracellular development of Chlamydia trachomatis.来自CD63阳性晚期内吞多囊泡体的转运对于沙眼衣原体的细胞内发育至关重要。
J Cell Sci. 2006 Jan 15;119(Pt 2):350-9. doi: 10.1242/jcs.02733.
9
Emergence of resistance to rifampin and rifalazil in Chlamydophila pneumoniae and Chlamydia trachomatis.肺炎嗜衣原体和沙眼衣原体对利福平及利福拉齐耐药性的出现。
Antimicrob Agents Chemother. 2005 Mar;49(3):903-7. doi: 10.1128/AAC.49.3.903-907.2005.
10
Lipid raft-mediated entry is not required for Chlamydia trachomatis infection of cultured epithelial cells.沙眼衣原体感染培养的上皮细胞并不需要脂筏介导的进入过程。
Infect Immun. 2004 Dec;72(12):7367-73. doi: 10.1128/IAI.72.12.7367-7373.2004.